Background-Graft arterial disease (GAD) limits long-term solid-organ allograft survival. The thickened intima in GAD contains smooth muscle-like cells (SMLCs), leukocytes, and extracellular matrix. The intimal SMLCs in mouse GAD lesions differ from medial smooth muscle cells in their function and phenotype. Although intimal SMLCs may originate by migration and modulation of donor medial cells or by recruitment of host-derived precursors, the mechanisms that underlie their localization within grafts and the factors that drive these processes remain unclear. Methods and Results-This study of aortic transplantation in mice demonstrated an important function for chemokines beyond their traditional role in leukocyte recruitment and activation. Intimal SMLCs, but not medial smooth muscle cells, express functional CC chemokine receptor-1 (CCR1) and respond to RANTES by increased migration and proliferation. Although RANTES infusion in vivo promoted inflammatory cell accumulation in the adventitia of aortic allografts of wild-type and CCR1-deficient recipients, it increased GAD intimal thickening with SMLC proliferation in only the wild-type hosts. Aortic allografts transplanted into CCR1-deficient mice after wild-type bone marrow transplantation did not develop intimal lesions, which indicates that CCR1-bearing inflammatory cells do not contribute to intimal lesion formation. Moreover, RANTES induced SMLC proliferation in vitro but did not promote medial smooth muscle cell growth. Blockade of CCR5 attenuated RANTES-induced T-cell and monocyte/macrophage proliferation but did not affect RANTES-induced SMLC proliferation, consistent with a larger role of CCR1-binding chemokines in SMLC migration and proliferation and GAD development. Conclusions-These studies provide a novel mechanistic insight into the formation of vascular intimal hyperplasia and suggest a novel therapeutic strategy for preventing allograft arteriopathy.
D espite contemporary therapies that effectively limit acute rejection, solid-organ allografts can still develop severe and diffuse arterial intimal hyperplastic lesions (graft arterial disease [GAD]) that constitute a major obstacle to long-term success. GAD lesions consist primarily of smooth muscle-like cells (SMLCs) and extracellular matrix, admixed with infiltrating mononuclear leukocytes, 1, 2 and can lead to progressive organ ischemia.
Clinical Perspective on p 1813
GAD occurs predominantly as a consequence of immunemediated allospecific vascular injury in grafts. 1 Host inflammatory cells initially interact with allografts at the vascular wall interface. Alloresponses induce the expression of cytokines, chemokines, adhesion molecules, and growth factors from activated donor endothelial cells and medial smooth muscle cells (SMCs), as well as from host inflammatory cells. The inflammatory events subsequently induce the accumulation and proliferation of intimal cells bearing SMC markers ("modulated" SMCs 3 ) and eventually obstruct the arteries of the allografted organ.
Because numerous important functional differences exist between intimal and medial SMCs, we refer to the intimal smooth muscle (SM) ␣-actin-positive cells as SMLCs. 4 SMLCs have a spindle-shaped, oval nucleus and cytoplasmic filaments, as do medial SMCs; they also express SMC markers, including SM ␣-actin, calponin, and SM-specific myosin heavy chain type 1 (SM1). 4 However, these intimal SMLCs differ distinctly from medial SMCs. Although medial SMCs typically contain abundant myofilaments and prolifer-ate slowly, if at all, intimal SMLCs more closely resemble those within developing embryonic vessels.
Since the 1960s, various groups have investigated the origins of SMLCs in vascular hyperplastic lesions. 5 Ross 6 hypothesized that during atherogenesis, platelet products and (in later formulations) local inflammatory events can activate medial SMCs, which then migrate into the intima, proliferate, and elaborate extracellular matrix; however, more recent studies indicate that some SMLCs in GAD lesions can derive from the host. 4, 5, 7 In nonimmunosuppressed animal aortic and cardiac allografts, host-derived SMLCs form the majority of intimal cells. In contrast, studies of human transplant recipients treated with immunosuppressant agents demonstrated that arterial allograft lesions have a substantially smaller proportion of host-derived SMLCs; in human heart GAD, the population of SMLCs of recipient origin ranges between 2.6% and 30%. 5 Regardless, the SMLCs that make up the intimal lesions likely have diverse sources: Donor medial SMCs (donor); fibroblast-myofibroblast transdifferentiation (donor, host); adjacent host medial SMCs (host); endothelialmesenchymal transdifferentiation (donor, host); bone marrow-derived SM precursor (host); and non-marrow-derived SMC precursor (host). 5 Bone marrow-derived cells constitute only 10% to 15% of the intimal SMLCs in mouse GAD, 4 which makes precursor cell characterization difficult. Overall, the multiple diverse origins of the SMLCs imply important differences in lineage that can figure mechanistically in the pathogenesis of GAD. Notably, bone marrow-derived SMLCs also populate human atherosclerotic lesions in bone marrow transplant (BMT) recipients. 8 Regardless of whether the intimal SMLCs derive from donor medial SMCs or host precursor cells, the growing intima must first recruit them. Moreover, intimal SMLCs proliferate and increase the size of the intimal lesion, whereas medial SMCs do not contribute. These observations suggest that intimal SMLCs selectively express chemokine and/or growth factor receptors that induce their recruitment and proliferation.
Classically, adhesion molecules and chemokines direct the recruitment of neutrophils, T cells, monocytes/macrophages, and other leukocytes into grafts and lead to vascular cell activation and tissue injury. Chemokines are 8-to 10-kDa peptides organized into CXC, CC, C, and CX 3 C subfamilies on the basis of the position of conserved cysteine residues. All chemokine receptors belong to a superfamily of Gprotein-coupled receptors, the differential expression of which on cells leads to selective chemokine function. 9 In vitro characterization suggests substantial redundancy and promiscuity in chemokine receptor interactions; each receptor binds multiple chemokines, and most chemokines bind to more than 1 receptor. 9, 10 Nevertheless, in vivo experiments show that an individual ligand or receptor deficiency can have striking effects. 11, 12 Clinical and animal studies demonstrate the presence of many chemokines in allografts during acute rejection and during the development of GAD lesions. 13 Moreover, interruption of specific chemokine-receptor interactions reduces leukocyte recruitment into allografts and attenuates subsequent intimal hyperplasia. 14 Rejecting allografts specifically contain high levels of chemokines that bind CC chemokine receptor-1 (CCR1), CC chemokine receptor-2 (CCR2), or CX chemokine receptor-3 (CXCR3), such as RANTES (regulated on activation, normal T-cell expressed and secreted), monocyte chemotactic protein (MCP)-1, macrophage inflammatory protein 1-␣ (MIP1-␣), interferon-inducible protein 10 (IP-10), or interferon-inducible T-cell chemoattractant (I-TAC); antibodies that block these mediators attenuate GAD. [15] [16] [17] [18] However, whether these chemokines exclusively influence leukocyte recruitment or can affect other cell populations remains uncertain. The present study tested the hypothesis that SMLCs bear functional chemokine receptors distinct from medial SMCs that promote their recruitment into intimal lesions and/or in situ proliferation in the intima, contributing importantly to GAD formation.
Methods
Mice BALB/c (B/c; H-2d) and C57BL/6 (B6; H-2b) mice were purchased from Jackson Laboratories (Bar Harbor, Me). CCR1-deficient mice on a C57BL/6 background were a kind gift from Dr Craig Gerard (The Children's Hospital, Boston, Mass). 19 
Bone Marrow Transplantation
BMT was performed as described previously. 4 Briefly, 6-to 8-weekold male B6 WT or B6 CCR1 Ϫ/Ϫ mice received a lethal dose of whole-body irradiation (770 rad) from a cesium gamma source. Femurs and tibias of male 8-to 12-week-old B6 WT mice were excised, and the marrow was flushed with RPMI by use of a syringe with a 30-gauge needle. Irradiated recipients received 1.0ϫ10 7 bone marrow cells in 0.2 mL of RPMI by tail-vein injection. Engraftment of transplanted marrow cells was confirmed by flow cytometry and routinely comprised 80% to 90% CCR1-positive cells in peripheral circulating mononuclear cells. Aortic transplantation from B/c into B6 WT or B6 CCR1 Ϫ/Ϫ hosts was performed at least 4 weeks after BMT.
Murine SMC Isolation
Descending thoracic aortas or aortic allografts were harvested from recipient WT B6 mice 8 to 12 weeks after transplantation with sterile microdissecting scissors under a dissecting microscope. After the adventitia was removed carefully, aortas were soaked in 70% ethanol for 5 minutes, then placed in a 60-mm Petri dish, cut into pieces, and incubated in Dulbecco's modified Eagle's medium (DMEM, Invitrogen, Grand Island, NY) with 1 mg/mL type II collagenase (Worthington Biochemical Corp, Lakewood, NJ) and 10% fetal bovine serum (FBS) for 1 hour at 37°C. Digested tissue and medium were transferred to a 50-mL conical polypropylene tube and centrifuged for 10 minutes; the medium was aspirated off, and cells were resuspended in 40 mL of fresh medium. After further centrifugation, cells were resuspended in fresh culture medium (DMEM with 10% FCS, 1% penicillin/streptomycin; Invitrogen) and 1% glutamine (BioWhittaker) and incubated in a 60-mm Petri dish. The purity of the SMLC and SMC cultures was Ͼ95%, as determined by immunofluorescence with anti-SM ␣-actin and SM1 antibodies. SMCs and SMLCs of passages 4 to 8 were used for the study.
RNase Protection Assay
RNase protection assays for chemokine receptor messenger RNA (mRNA) were conducted with multiprobe templates according to the manufacturer's protocol (RiboQuant assay kit, BD Pharmingen). Gels were scanned and radioactive bands quantified with a phosphorimager (Molecular Dynamics, Sunnyvale, Calif) with normalization against the GAPDH housekeeping gene.
Fluorescence Confocal Microscopy
Frozen slide samples of human cardiac allografts or murine aortic allografts were fixed with 4% paraformaldehyde, blocked with 5% goat serum, and incubated with antibodies (anti-CCR1, anti-SM ␣-actin, or anti-BrdU) and appropriate secondary antibodies. For confocal microscope analysis, we used a Zeiss LSM 510 UV Meta laser scanning confocal microscope (Carl Zeiss International, Oberkochen, Germany) at ϫ63 magnification. Images were analyzed with Zeiss imaging software.
Colocalization Analysis
We analyzed confocal microscope images for colocalization of SM ␣-actin, CCR1, or BrdU through ImageJ (WS Rasband, National Institutes of Health, Bethesda, Md; http://rsb.info.nih.gov/ij/). Acquired images were analyzed as individual green and red channels that corresponded to SM ␣-actin (green) and anti-CCR1 (red) staining or SM ␣-actin (green) and BrdU (red) staining, respectively.
Background staining was corrected with the background subtraction function on ImageJ. Regions of interest were selected on the basis of patching patterns in both red and green channels. Areas that contained staining artifacts, as indicated by intense regions of fluorescence in both channels, were excluded from analysis. A Manders overlap coefficient, a measure of overlap of the red and green signals, was generated with the Manders coefficient plug-in, 22 which is included in the Wright Cell Imaging Facility version of ImageJ (http://www.uhnresearch.ca/facilities/wcif/imagej/), with regions of interest for analysis set for the green channel. Coefficients for 10 separate images were averaged.
SMC Proliferation Assay
SMCs and SMLCs were plated (1ϫ10 4 cells/well) in quadruplicate to 96-well flat-bottom tissue culture plates (Costar, Cambridge, Mass), maintained in DMEM with 10% FBS, and incubated at 37°C in a humidified atmosphere of 5% CO 2 . At confluence, cells were serum-deprived for 48 hours before treatment with chemokines with or without a phosphatidylinositol 3-kinase inhibitor (wortmannin) or mitogen-activated protein kinase (MAPK) inhibitors (SB202190, SP600125 [a c-Jun N-terminal kinase inhibitor], or PD98059). Cell proliferation was assessed by pulsing the wells for 6 hours with 1 Ci of tritiated thymidine (New England Nuclear, Boston, Mass). Proliferation was measured as incorporated radioactivity (counts per minute) with a Betaplate scintillation counter (Pharmacia-Wallac, Gaithersburg, Md). Results were expressed as meanϮSEM. 23 For neutralizing CCR1, CCR3, or CCR5, we added 1 g/mL of rabbit anti-mouse CCR1 (sc-7934, Santa Cruz) polyclonal antibody, rat anti-mouse CCR3 (clone 83103, R&D Systems), or mouse antimouse CCR5 (sc-17833, Santa Cruz) monoclonal antibodies or control IgG (R&D Systems) to the culture medium. 20
Intracellular Ca 2؉ Influx Measurement
Intracellular Ca 2ϩ influx measurement was performed with a Fluo-4NW (no wash) calcium assay kit (Molecular Probes, Carlsbad, Calif). Cells were seeded on a 96-well black plate (Packard Bio-Science, Meriden, Conn) in DMEM with 10% calf serum. After cells grew to 90% confluence, they were starved with serum-free medium for 48 hours. Cells were loaded with 90 L of 1 mol/L Ca 2ϩsensitive fluorescent dye Fluo-4NW for 30 minutes at 37°C and 30 minutes at room temperature, and 10 L of 10ϫ various chemokine solutions was added to each well (nϭ4 for each chemokine) after 60 seconds of reading. Fluorescence signals (excitation 485 nm, emission 525 nm) were measured by the fluorescence microplate reader for 10 minutes at sampling intervals of 3 seconds. The basal fluorescence intensity was subtracted from the maximum fluorescence intensity to estimate intracellular Ca 2ϩ .
SMC Migration Assay
Migration was measured with 48-well modified Boyden chambers 24 with polycarbonate filter membranes with 8-m pores (Nalge Nunc International, Rochester, NY). A total of 50 000 SMLCs or medial SMCs in 0.2% FBS DMEM medium was seeded to the upper well of the Boyden chamber. Recombinant chemokines (100 ng/mL, RANTES or MIP1-␣) were loaded in quadruplicate wells of the lower Boyden chamber with 0.2% FBS DMEM medium; 0.2% FBS in DMEM with or without platelet-derived growth factor-BB (PDGF-BB; 20 ng/mL) served as a positive or negative control, respectively. After 48 hours of incubation, cells were trypsinized, washed 3 times with PBS, and counted with a hemocytometer. Cell viability was determined by trypan blue exclusion. Values are expressed as the ratio of cells that migrated in response to negative control (0.2% FBS in DMEM).
Western Blots
For CCR1 staining, we extracted proteins from cultured intimal SMLCs, cultured medial SMCs, WT C57BL6 spleen, or CCR1 Ϫ/Ϫ spleen with RIPA buffers with proteinase inhibitors (Sigma). For c-Jun N-terminal kinase inhibitor (JNK) staining, intimal SMLCs were treated for the indicated time with RANTES 100 ng/mL with or without MAPK inhibitors. Cell lysates with RIPA buffers with phosphatase inhibitors (Sigma) were loaded and separated by 10% SDS-PAGE. After transfer to Zeta-probe blotting membranes (Bio-Rad, Richmond, Calif), blots were blocked overnight with 5% dry milk in TBS buffer (125 mmol/L NaCl, 25 mmol/L Tris, pH 8.0, 0.05% Tween 20) at 4°C and then probed with antibody (1 g/mL) against CCR1 or unphosphorylated or phosphorylated JNK (Cell Signaling, Beverly, Mass). Enhanced chemiluminescence (Amersham, Piscataway, NJ) was used for detection.
Statistical Analysis
Numerical data with normal distribution are presented as meanϮSD. Comparisons between 2 groups with normally distributed data with equal or unequal variance were performed with a 1-way ANOVA or 2-sample t test for unequal variance, respectively. Because the GAD lesion area was not normally distributed, the Mann-Whitney test was used to evaluate differences in intimal lesion area. Statview 4.5 for Macintosh, STATA 10, or GraphPad Prism 5 software was used for all statistical calculations.
Results

Intimal SMLCs Express Significantly Higher Levels of CCR1 Than Medial SMCs
To characterize the behavior and characteristics of intimal SMLCs versus medial SMCs, we developed a method for primary SMLC culture from murine aortic allografts. In 8-to 12-week-duration murine aortic allografts transplanted across major histocompatibility barriers (online-only Data Supplement Figure IA) , early vigorous rejection virtually eliminated the original donor medial SMCs 4 (online-only Data Supplement Figure IIB) . Consequently, culture of these 8-to 12-week aortic allografts permitted isolation of a population highly enriched for intimal SMLCs. We cultured medial SMCs from native, uninjured recipient aortas. The cultured SMCs from these 2 sources had comparable patterns of SM ␣-actin staining on confocal microscopy (online-only Data Supplement Figure III) . Demonstration that SMLCs express chemokine receptors distinct from medial SMCs entailed the extraction of total RNA from cultured intimal SMLCs and medial SMCs with or without prior cytokine stimulation and the performance of an RNase protection assay. Intimal SMLCs, but not SMCs, expressed CCR1 mRNA after treatment with interferon-␥ and tumor necrosis factor-␣ ( Figure 1A) . Neither intimal SMLCs nor medial SMCs expressed mRNA for CCR2, CCR3, CCR4, CCR5, CXCR2, CXCR3, or CXCR4 ( Figure 1A ). Affymetrics GeneChip experiments (mouse GeneChip U74) with cDNA constructed from total RNA from cultured intimal SMLCs and medial SMCs after combined interferon-␥ and tumor necrosis factor-␣ stimulation yielded the same results (ie, that CCR1 expression was the only difference in chemokine receptor expression between intimal SMLCs and medial SMCs; Figure 1B ).
We used Western blots of protein extracts from cultured intimal SMLCs and medial SMCs to determine CCR1 protein levels. Proteins extracted from spleens of WT C57BL/6 (B6; H-2b) mice served as positive controls and those from B6 CCR1-deficient animals served as negative controls. Western blots showed that cytokine-stimulated intimal SMLCs had greater expression of CCR1 protein than either B6 or BALB/c (B/c; H-2d) medial SMCs ( Figure 1C , a and b). Flow cytometry also showed higher mean fluorescence intensity of CCR1 expression in intimal SMLCs than in B6 medial SMCs ( Figure 1D ).
Intimal SMLCs of GAD Lesions of Human Cardiac Allografts and Murine Aortic Allografts Express CCR1
Confocal immunofluorescence microscopy identified CCR1positive cells that colocalized with SM ␣-actin-positive cells in the intima of GAD lesions in human cardiac allografts (Figure 2A , a-c); however, SM ␣-actin-positive cells in medial SMCs (Figure 2A , d through f) and normal aortic intimal cells (Figure 2A , g through i) did not express CCR1. A majority of SM ␣-actin-positive cells in GAD lesions were also CCR1-positive (64.6Ϯ8.6%, nϭ10), as shown by fluorescent intensity spectrum analysis ( Figure 2B , a and b), with a Manders coefficient of 0.86Ϯ0.02 (nϭ10). 22 Similarly, confocal immunofluorescence microscopy identified CCR1positive cells that colocalized with SM ␣-actin-positive cells in intimal lesions in BALB/c aortic allografts in C57BL6 host 8 weeks after transplantation ( Figure 2C , a through c) but not in medial SMCs ( Figure 2C , d through f). A majority of SM ␣-actin-positive cells in murine GAD lesions were also CCR1-positive (57.2Ϯ13.2%, nϭ10), whereas only 8.1Ϯ0.9% (nϭ10, PϽ0.0001) of medial SMCs stained pos- itively for CCR1 ( Figure 2D, a and b) , with a Manders coefficient in GAD lesions of 0.87Ϯ0.02 (nϭ10). Thus, intimal SMLCs had a pattern of chemokine receptor expression distinct from that of medial SMCs in human and murine GAD.
CCR1 Ligand RANTES Induces Intimal SMLC but Not Medial SMC Proliferation
Murine CCR1 ligands include MIP1-␣ (CCL3), RANTES (CCL5), C10 (CCL6), MARC (MARC/MCP-3/CCL7), MCP-2 (CCL8), and MIP1-␥ (CCL9/10). In addition to CCR1, MIP1-␣ binds to CCR5, RANTES binds to CCR3 and CCR5, MARC binds to CCR2 and CCR3, and MCP-2 binds to CCR2, CCR3, and CCR5. C10/CCL6 shares substantial sequence similarity with several chemokines, including MIP-1␥/CCL9/10, HCC-1/CCL14, and MIP-1␦/CCL15. [25] [26] [27] In contrast to the prototypical CC chemokines, CCL14 and CCL15 have 4 exons, with a characteristic second exon that contributes importantly to their biological effects. 28 These homologous chemokines particularly attract T cells and monocytes. 25 To examine whether CCR1 ligation induces intimal SMLC or medial SMC proliferation, we assayed 3 Hthymidine incorporation after treatment with various CCR1 ligands ( Figure 3A) . RANTES, C10, and MARC induced concentration-dependent intimal SMLC proliferation but did not cause medial SMC proliferation. In contrast, MIP-1␣ and MIP-1␥ did not stimulate proliferation of either intimal SMLCs or medial SMCs.
CCR1 Ligand RANTES Induces Significantly Higher Ca 2؉ Influx by Intimal SMLCs Than Medial SMCs
Ca 2ϩ influx importantly regulates growth factor-mediated SMC proliferation 29, 30 ; PDGF also activates Ca 2ϩ entry into vascular SMCs in the absence of intracellular Ca 2ϩ mobilization. 29 To examine the effects of CCR1 ligation on intracellular calcium influx, we labeled intimal SMLCs and medial SMCs with Fluo-4 NW and stimulated them with various ligands; an increase in fluorescence signal corresponded to a rise in intracellular Ca 2ϩ in the Fluo4-labeled SMCs. Intimal SMLCs treated with RANTES showed the largest Ca 2ϩ influx among the various CC chemokines tested ( Figure 3B ). RANTES, C10, or MARC elicited significantly more fluorescence in intimal SMLCs than medial SMCs (PϽ0.005). Although MIP-1␣ and MIP-1␥ did not affect SMC proliferation, MIP-1␣-treated and MIP-1␥-treated intimal SMLCs nevertheless showed significantly higher calcium influx responses than medial SMCs (Pϭ0.0003). Intimal SMLCs and medial SMCs treated with PDGF showed comparably strong responses (630.4Ϯ68.9 in intimal SMLCs and 620.0Ϯ156.0 in medial SMCs, Pϭ0.8949).
CCR1 Ligand RANTES Induces Intimal SMLC but Not Medial SMC Migration
We then performed a migration assay using cultures of intimal SMLCs or medial SMCs with modified Boyden chamber methods. PDGF-BB served as a positive control; the absence of chemokines or PDGF-BB served as a negative control. Intimal SMLCs cultured with RANTES showed augmented migration rates compared with medial SMCs ( Figure 3C ). In contrast, intimal SMLCs and medial SMCs cultured with MIP-1␣, negative control, or PDGF-BB showed comparable migration rates ( Figure 3C ). We also performed an alternative migration assay using cultures of intimal SMLCs or medial SMCs adjacent to HEK293 cells transfected with various chemokines (RANTES, C10, and MIP-1␣); transfected PDGF-BB served as a positive control, and transfected green fluorescent protein served as a negative control. Intimal SMLCs cocultured with RANTES-or C10transfected HEK293 cells showed augmented migration rates compared with medial SMCs (online-only Data Supplement Figure IV) . In contrast, intimal SMLCs and medial SMCs cocultured with MIP-1␣-transfected, control (green fluorescent protein)-transfected, or PDGF-transfected HEK293 cells showed comparable migration rates. The concentration of C10, RANTES, MIP-1␣, and PDGF-BB in the coculture medium ranged from 20 to 60 ng/mL.
CCR3 Ligation and CCR5 Ligation Do Not Affect Intimal SMLC Proliferation
RANTES can bind CCR1, CCR3, and CCR5. Several investigators reported that SMCs express CCR1, as well as CCR3 and CCR5, 14, 31, 32 although in the present study, RNase protection assay did not detect CCR3 or CCR5 mRNA expression by intimal SMLCs. To examine whether RANTES can ligate CCR3 or CCR5 and induce SMLC proliferation, we treated SMLCs with RANTES and assayed 3 H-thymidine incorporation with anti-CCR3 or anti-CCR5 blocking antibody versus isotype control monoclonal antibodies. Intimal SMLCs cultured with RANTES 100 ng/mL and anti-CCR3 or -CCR5 blocking antibody or control IgG 1 g/mL showed comparable 3 H-thymidine incorporation ( Figure 3D ), which indicates that neither CCR3 or CCR5 ligation affected the proliferation of intimal SMLCs. Of note, the absence of neutralizing antibodies or small molecules to inhibit CCR1 binding by its ligands in rodents prevented us from performing comparable CCR1-blocking experiments.
JNK Signaling Pathways Involve RANTES-Induced SMLC Proliferation
Phosphatidylinositol 3-kinase and MAPK pathways can participate in SMC migration and proliferation. 33, 34 To assess the roles of the MAPK and phosphatidylinositol 3-kinase pathways in chemokine-induced SMLC proliferation, RANTESor C10-stimulated SMLCs (100 ng/mL) were incubated with SB202190 (p38 inhibitor), SP600125 (JNK inhibitor), wortmannin (phosphatidylinositol 3-kinase inhibitor), or PD98059 (inhibitor of MEK1 [MAPK/extracellular signal-regulated kinase kinase]). PD98059 and SP600125 significantly reduced RANTES-and C10-induced SMLC proliferation ( Figure 4A ), whereas treatment with either the PI-3 kinase inhibitor wortmannin or the p38 inhibitor SB202190 did not affect SMLC proliferation ( Figure 4A ). RANTES also induced phosphorylation of extracellular signal-regulated kinase and JNK in SMLCs ( Figure 4B ). Consistent with an important role for JNK signaling pathways in RANTES-induced SMLC proliferation, JNK small interfering RNA significantly reduced JNK expression ( Figure 4C ) and RANTES-induced 3 H-thymidine incorporation in SMLCs ( Figure 4D ).
Host CCR1 Depletion Attenuates Aortic Allograft GAD
To evaluate whether CCR1 signaling attenuates GAD in vivo, we performed aortic transplantation using a fully allomismatched (major histocompatibility complex class I and class II mismatched) combination of B/c (H-2d) and B6 (H-2b) mice. Thoracic aortic donor grafts were anastomosed into host infrarenal abdominal aortas and harvested 8 weeks after transplantation. No immunosuppressive agent was administered to avoid confounding effects on inflammatory cell accumulation. Aortic allografts in B6 CCR1-deficient hosts showed significantly reduced GAD lesions compared with allografts in WT (B6 WT) recipients ( Figure 5A ; PϽ0.001).
To ensure that the effect of host CCR1 deficiency did not derive from diminished inflammatory cell recruitment, we examined aortic allografts 1 week after transplantation, at the peak of acute rejection. 4 Aortic allografts in B6 CCR1deficient hosts showed comparable numbers of CD4ϩ and CD8ϩ cells and CD11bϩ macrophages relative to WT recipient allografts ( Figure 5B) ; moreover, subsequent harvest at 8 weeks showed a complete loss of donor medial SMCs ( Figure 5A ), which indicates a comparable degree of allograft rejection. This result indicates that CCR1 depletion alone does not affect T-cell and macrophage migration, accumulation, or activity in vivo and suggests that redundant pathways allow inflammatory cell recruitment in the absence of CCR1.
RANTES Induces Intimal SMLC Proliferation In Vivo in Aortic Allografts
To evaluate whether CCR1 ligation induces intimal SMLC proliferation and intimal thickening in vivo, we performed aortic transplantation followed by continuous RANTES or PBS (control) infusion for 4 weeks ( Figure 6A ). Each aortic allograft recipient also received BrdU infusion for 4 weeks before harvest of the donor aortas to assess in vivo DNA replication in intimal SMLCs. 35 Neither RANTES or PBS infusion induced intimal thickening in B6 CCR1 Ϫ/Ϫ recipient allografts ( Figure 6B, a and Figure 6B , c through f).
The intimal lesions of B6 WT recipients receiving RANTES infusion also contained significantly more BrdU-labeled nuclei than those of B6 recipients that received PBS ( Figure 6C , a through f). The labeling index calculated from the percentage of BrdU-labeled cells relative to the total number of SM ␣-actin-positive cells in the intimal lesions showed marked augmentation of DNA replication in RANTES-treated recipient allografts (63.2Ϯ7.8%, nϭ9, versus 26.3Ϯ7.2%, nϭ12, in PBS-treated B6 WT recipient allografts; PϽ0.0001; Figure  6C , g). These results demonstrate that intimal SMLCs, but not medial SMCs, express functional CCR1 and that CCR1 signaling promotes SMLC proliferation and GAD development in vivo.
RANTES Infusion Increases Inflammatory Cell Accumulation in CCR1 ؊/؊ Recipient Allografts but Does Not Drive GAD Development
RANTES can ligate both CCR1 and CCR5 expressed on T cells and monocyte/macrophages and thereby stimulate these inflammatory cells. RANTES infusion possibly stimulates inflammatory cells, subsequently and indirectly inducing SMLC proliferation. To examine whether RANTES infusion
modulates inflammatory cell accumulation in the aortic allografts, we performed immunohistochemistry ( Figure 7A ). Indeed, RANTES infusion significantly increased CD4ϩ (T cell) and MAC3ϩ (macrophage) cell accumulation in the aortic allografts of WT hosts compared with PBS infusion. By the same token, RANTES infusion significantly increased inflammatory cell accumulation in CCR1 Ϫ/Ϫ recipient allografts ( Figure 7B) , even though such infusion did not drive GAD development ( Figure 6 ). The study indicated that RANTES can modulate inflammatory cell accumulation in GAD lesions (presumably via CCR5), but SMLCs require CCR1 ligation for SMLC proliferation and intimal lesion formation.
Aortic Allografts of B6 CCR1 ؊/؊ Host Receiving B6 WT Bone Marrow Do Not Develop Intimal Lesions
Because inflammatory cells also express CCR1 and can conceivably contribute to GAD by driving the extent of allograft rejection, we specifically examined whether CCR1bearing inflammatory cells contributed to intimal lesion formation. We therefore transplanted B6 WT bone marrow into either irradiated B6 WT or B6 CCR1-deficient mice (BMT); 2 weeks later, we performed aortic transplantation into these BMT hosts. If CCR1-bearing inflammatory cells contribute importantly to intimal lesion formation, the aortic allografts in B6 CCR1 Ϫ/Ϫ hosts receiving B6 WT bone marrow should have induced intimal lesion formation; however, this was not the case (Figure 8 ). Allografts in CCR1deficient hosts showed significantly reduced intimal area due to GAD (median [interquartile range] 0.005 [0 to 0.03] mm 2 , nϭ4, Pϭ0.001) compared with allografts in WT recipients (0.19 [0.14 to 0.265] mm 2 , nϭ4). B6 CCR1 Ϫ/Ϫ host allografts did not develop intimal lesions after B6 WT BMT, which indicates that CCR1-positive inflammatory cells do not contribute importantly to intimal lesion formation. 
Discussion
This study demonstrates a number of important findings: Intimal SMLCs but not medial SMCs express higher levels of CCR1 in human and murine GAD lesions; CCR1 ligation by RANTES induces intimal SMLC migration and proliferation in vitro; aortic allografts in CCR1-deficient recipients show significantly reduced GAD development despite the recruitment of graft-infiltrating lymphocytes comparable to WT hosts; and RANTES accelerates GAD lesion formation with intimal SMLC proliferation in murine aortic allotransplantation.
A previous study by Gao et al 36 demonstrated attenuation of GAD in cardiac allografts transplanted into CCR1deficient hosts. The administration of anti-CD4 antibody and cyclosporine confounded these studies 36 and precluded the conclusion that the effect resulted from blockade of the recruitment of inflammatory cells versus other cell types. The investigators concluded that CCR1 contributed in part to the reduction of graft accumulation of inflammatory cells, thereby attenuating chronic rejection. Notably, the authors also reported that CCR1 depletion alone did not affect the accumulation of graft inflammatory cells in the absence of anti-CD4 antibody or cyclosporine. 36 Heightened expression of a large variety of chemokines accompanies GAD development. 14 In the acute setting, che-mokines recruit leukocytes, which promotes damage to the donor organ; however, during chronic allograft responses, vascular wall-or leukocyte-derived chemokines may exert other important actions in GAD pathogenesis, 15, 37 specifically in the recruitment and activation of SMLC precursors. RANTES, in particular, can arise from endothelial cells, T cells, macrophages, and platelets. 15, 38 Although RANTES can activate monocytes/macrophages bearing CCR1 or CCR5 when immobilized on the surfaces of endothelial cells and promotes monocyte/macrophage migration when localized in this fashion, 39 the present study makes the point that mononuclear inflammatory cell recruitment into allografts does not require CCR1 expression.
Conversely, intimal SMLC recruitment does not take place in the absence of CCR1. Although several receptors can bind RANTES, including CCR1, CCR3, and CCR5, 40 SMLCs express only functional CCR1. RANTES ligation of SMLC CCR1 induces their proliferation and migration. In addition, other CC chemokines not typically elaborated in rejecting allografts (including C10 and MARC) can also induce SMLC proliferation. RANTES may activate SMLCs via the MAPK pathway in SMLCs, as evidenced by extracellular signalregulated kinase and JNK phosphorylation, and in accordance with findings in other cell types. 41 The present study demonstrated that among the known CCR1 ligands, RANTES most potently induces intimal SMLC proliferation. Various CCR1 ligands may behave differently with regard to intimal SMLC proliferation, perhaps because of binding to other CC chemokine receptor(s) or because of different binding affinity. A semiquantitative chemokine binding assay with fluorescent chemokine ligands (online-only Data Supplement Figure V) showed that CCR1 had relatively lower binding affinity for RANTES relative to MIP-1␣ (IC 50 was 2.6Ϯ0.2 versus 1.3Ϯ0.2 ng/mL, respectively). Other investigators have also shown different affinities of various CC chemokine ligands (MIP-1␣ and RANTES) to CCR1; Gao et al 42 found that MIP-␣ and RANTES induced calcium influx in human polymorphonuclear leukocytes with an EC 50 of 5 and 50 nmol/L, respectively, which indicates that MIP-1␣ has a higher affinity for CCR1 than RANTES. However, binding affinity does not predict signaling efficacy through this receptor. 43 MIP-1␣ exhibits both the highest binding and signaling affinity. Nevertheless, although RANTES binds with a lower affinity (K d of 460 nmol/L), it transmits a Ca 2ϩ signal with much greater efficacy than MIP-1␣. 43 Several observations suggest that RANTES might interact differently with CCR1 than does MIP-1␣. Neote et al 43 showed that CCR1-transfected cells clearly mobilize Ca 2ϩ in response to as little as 1 nmol/L RANTES and that CCR1transfected cells are desensitized in their ability to flux Ca 2ϩ in response to RANTES. The physiological significance of chemokine binding and consequent signal transduction via CCR1 receptor requires further investigation.
Human intragraft vascular cells express high levels of IP-10/CXCL10, I-TAC/CXCL11, and CXCR3, and plasma levels of I-TAC are elevated in patients with severe GAD. 16, 17 Stromal cell-derived factor 1␣ (SDF-1 ␣)/CXCR4 also appears important for endothelial cell and SMLC progenitor cell trafficking to and from the bone marrow and for migration to injured peripheral organs. 44, 45 Previous studies demonstrated that SMCs can express CCR1 (airway SMCs), 32 CCR2 (rat aortic SMCs), 46 CCR3 (airway SMCs, mouse aortic SMCs), CCR5, CCR8, CXCR3, and CXCR4. 14, 31, 32, 46 Indeed, various chemokines, including IP-10 (rat vascular SMCs), 47 SDF-1, 45 MCP-1, 48,49 CC chemokine ligand 1 (CCL1, I-309, rat aortic SMCs), 46 and eotaxin (CCL11), 50 promote or inhibit SMC migration or proliferation. 14 CXCR3 chemokines in particular exert potent biological effects on vascular cells in addition to their well-recognized effects on mononuclear inflammatory cells. Several studies define functional receptors as a "positive induction of calcium influx, MAPK phosphorylation, or tissue factor activity." 49 Regionspecific chemokine receptors may explain the pathogenesis of certain diseases, such as asthma. 32 However, no previous studies have differentiated intimal SMLCs in GAD lesions from medial SMCs in normal arteries. Polymerase chain reaction analysis can detect chemokine receptor mRNA with very high sensitivity so that it may detect mRNA derived from contaminating inflammatory cells. Western blot or flow cytometry would be a preferable methodology with a certain specificity. Several investigators have detected CCR3, CCR5, CXCR3, and CXCR4 in vascular SMCs, receptors whose cognate ligands can promote SMC migration and proliferation in vitro; however, these findings cannot explain the lack of medial SMC proliferation or expansion in GAD lesions, even when accompanied by increased expression of cognate ligands such as MCP-1, SDF-1, eotaxin, or RANTES. Indeed, infusion of RANTES (a ligand for CCR1, CCR3, and CCR5) did not induce medial SMC proliferation of normal arteries and aortas.
Clinical Implications
GAD remains a clinically important limitation to human cardiac transplantation. One-, 3-, 5-, and 10-year patient survival rates after adult heart transplantation are 88%, 80%, 74%, and 52%, respectively, 51 with the majority of mortality attributable to GAD. Intravascular ultrasound demonstrates GAD in 75% of patients at 3 years after transplantation 52, 53 ; significant vasculopathy can develop as early as 6 to 12 months after transplantation.
Intimal SMLCs predominate in GAD lesions. Ischemiareperfusion, allospecific humoral and cellular effectors, donor and host antigen-presenting cells, and atherogenic factors contribute to intimal lesion formation. Chemokines indirectly affect GAD formation because they contribute to ischemiareperfusion injury and acute rejection. 13 However, chemokines can also contribute directly to vascular remodeling and angiogenesis beyond their role in leukocyte chemotaxis. 5 Intimal SMLCs likely have multiple sources beyond simple recruitment from donor medial cells. Intimal SMLCs are clonal and phenotypically distinct from medial SMCs 54 -57 ; SMLCs express hematopoietic markers such as CD14, CD34, CD105, Thy-1, c-kit, flt1, and flt-3. 58 -60 In any event, bone marrow-derived or any other circulating precursor cell must access grafts from the circulation 5, 61 ; the presence of SM progenitor cells in human peripheral blood corroborates this notion. 59, 60 We hypothesized that SMLC receptors and their cognate ligands promote intimal lesion formation. Such receptors must preferentially target SMLCs compared with intrinsic arterial SMCs. The present study demonstrates that RANTES can potentiate the effects of proliferative signals and implies that chemokines contribute to both recruitment and expansion of intimal cells in GAD lesions. Clinical application will require further studies evaluating the effect of CCR1 depletion and immunosuppressive therapy, alone or in combination, on allograft rejection and GAD.
Study Limitations
We examined the function of CCR1 of SMLCs on GAD in the setting of total allomismatched murine aortic transplants without immunosuppression. This condition does not completely recapitulate human solid-organ transplantation. We demonstrated that intimal SMLCs express CCR1 both by immunohistochemistry and by a number of in vitro molecular and cellular techniques, but immunohistochemistry on tissue specimens cannot exclude the possibility of contamination of transdifferentiated inflammatory cells (although these cells might serve as 1 of the SMLC precursors). CCR1 depletion may affect the development and function of immune cells. The present experiments with RANTES infusion and BMT of normal cells into CCR1-deficient allograft recipients provide compelling evidence for the importance of SMLCs bearing CCR1 in chronic rejection. Nonetheless, we cannot rule out an inflammatory cell chemoattracting role of CCR1 and other chemokine receptors in the development and function of immune cells and SMCs.
Conclusions
The present study demonstrated a critical function for CCR1 and RANTES in the pathogenesis of GAD beyond leukocyte recruitment. Intimal SMLCs, but not medial SMCs, express functional CCR1 that responds to RANTES by proliferation and increased migration. In the absence of host CCR1, normal allograft inflammatory cell recruitment can occur, but GAD is attenuated. These results provide new pathophysiological insight into the mechanisms of GAD and suggest novel therapeutic strategies for the prevention of allograft arteriopathy.
